SGLT2 Inhibitor Market size was valued at USD 12.34 Billion in 2024 and is forecasted to grow at a CAGR of 9.5% from 2026 to 2033, reaching USD 25.67 Billion by 2033.
In 2023, the global SGLT2 inhibitors market generated revenue of USD 15,852.3 million and is projected to reach USD 29,427.0 million by 2030, growing at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2030. North America dominated the market with a 40.9% share in 2023, driven by a high prevalence of diabetes and a well established healthcare infrastructure. Europe followed, accounting for approximately 30% of the global market in 2023, with countries like Germany, the United Kingdom, and France leading due to increasing awareness and government initiatives in diabetes management. The Asia Pacific region is emerging as the fastest growing market for SGLT2 inhibitors, primarily due to its large diabetic population and improving healthcare access. Countries such as China, India, and Japan are experiencing a surge in diabetes cases, fueled by lifestyle changes, urbanization, and aging populations. The Asia Pacific market is projected to grow at a CAGR of 12% from 2024 to 2032. Latin America and the Middle East & Africa regions held smaller market shares in 2023 but are expected to witness growth due to rising awareness and increasing prevalence of diabetes.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=860804&utm_source=Google_Site_May&utm_medium=226
Eli Lilly
Boehringer Ingelheim
Johnson & Johnson
AstraZeneca
Merck
Pfizer
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=860804&utm_source=Google_Site_May&utm_medium=226
Growing demand for below applications around the world has had a direct impact on the growth of the Global SGLT2 Inhibitor Market
Dapagliflozin
Canagliflozin
Empagliflozin
Ertofazol
Remogliflozin
Oral
Injectable
Adults (18-65 Years)
Elderly (65 Years and Older)
With Metformin
With Insulin
With DPP-4 Inhibitors
Type 2 Diabetes Mellitus
Heart Failure
Chronic Kidney Disease
Weight Management
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/sglt2-inhibitor-market/
1. Introduction of the Global SGLT2 Inhibitor Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global SGLT2 Inhibitor Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global SGLT2 Inhibitor Market, By Type
6. Global SGLT2 Inhibitor Market, By Application
7. Global SGLT2 Inhibitor Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global SGLT2 Inhibitor Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/